Senators call on HHS to investigate McKinsey's alleged ties with FDA, opioid manufacturers
McKinsey may be in even deeper trouble than it seemed last year. Last summer, Senate Democrats called on the FDA to look into accusations that the consulting firm failed to disclose potential conflicts of interest as it worked with both the regulatory agency and opioid manufacturers at the same time.
Unsatisfied with the answers they got, the lawmakers are now turning to the HHS’ inspector general for some resolution.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.